Fulgent Genetics Gestione
Gestione criteri di controllo 2/4
Fulgent Genetics Il CEO è Ming Hsieh, nominato in May2016, e ha un mandato di 8.5 anni. la retribuzione annua totale è $ 5.31M, composta da 18.8% di stipendio e 81.2% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 28.52% delle azioni della società, per un valore di $ 156.09M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 4.7 anni e 3.8 anni.
Informazioni chiave
Ming Hsieh
Amministratore delegato
US$5.3m
Compenso totale
| Percentuale dello stipendio del CEO | 18.8% |
| Mandato del CEO | 8.5yrs |
| Proprietà del CEO | 28.5% |
| Durata media del management | 4.7yrs |
| Durata media del Consiglio di amministrazione | 3.8yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Fulgent Genetics: An NCAV Pick With Profit And Growth Potential
Sep 25Fulgent Genetics: Core Growth Re-Acceleration Will Be The Critical Catalyst
Sep 09Some Shareholders Feeling Restless Over Fulgent Genetics, Inc.'s (NASDAQ:FLGT) P/S Ratio
Jul 17
Fulgent Genetics: Growth Is Returning
Jun 06Shareholders May Be Wary Of Increasing Fulgent Genetics, Inc.'s (NASDAQ:FLGT) CEO Compensation Package
May 10Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report
May 07Are Investors Undervaluing Fulgent Genetics, Inc. (NASDAQ:FLGT) By 32%?
Mar 01Fulgent Genetics: Buy Growth Ahead Below Liquidation Value
Feb 21Subdued Growth No Barrier To Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Price
Jan 17Is Fulgent Genetics (NASDAQ:FLGT) Using Debt Sensibly?
Dec 14Fulgent Genetics (NASDAQ:FLGT) Has Debt But No Earnings; Should You Worry?
Aug 09Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report
May 09Fulgent Genetics (NASDAQ:FLGT) Is Looking To Continue Growing Its Returns On Capital
Apr 19Why We Like The Returns At Fulgent Genetics (NASDAQ:FLGT)
Jan 15Does Fulgent Genetics (NASDAQ:FLGT) Have A Healthy Balance Sheet?
Dec 28What Does The Future Hold For Fulgent Genetics, Inc. (NASDAQ:FLGT)? These Analysts Have Been Cutting Their Estimates
Nov 16Why Fulgent Genetics, Inc. (NASDAQ:FLGT) Could Be Worth Watching
Oct 27Wait For Fulgent Genetics To Grow Up
Oct 13We Like Fulgent Genetics' (NASDAQ:FLGT) Returns And Here's How They're Trending
Sep 19Fulgent Genetics (NASDAQ:FLGT) Seems To Use Debt Rather Sparingly
Sep 05Fulgent Genetics: Poised To Survive Its Post-Covid Hangover
Jul 26Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Low P/E No Reason For Excitement
Jul 21Fulgent Genetics (NASDAQ:FLGT) Is Investing Its Capital With Increasing Efficiency
Jun 04Fulgent Is Putting Its Cash Bonanza To Work
May 15These 4 Measures Indicate That Fulgent Genetics (NASDAQ:FLGT) Is Using Debt Safely
May 04Fulgent Genetics: Now The Going Could Get Much Tougher
Apr 10Fulgent Genetics: COVID Bolstered The Underlying Business
Mar 17Fulgent Genetics: Somewhat Disappoints With A Marked Slowdown In Its NGS Business
Feb 27Fulgent Genetics Stock: 35% Off Its Recent Highs - It Is Now A Buy
Feb 09Fulgent Genetics: Sell Volatility
Jan 26Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$165m |
| Jun 30 2024 | n/a | n/a | -US$163m |
| Mar 31 2024 | n/a | n/a | -US$166m |
| Dec 31 2023 | US$5m | US$1m | -US$168m |
| Sep 30 2023 | n/a | n/a | -US$64m |
| Jun 30 2023 | n/a | n/a | -US$49m |
| Mar 31 2023 | n/a | n/a | -US$26m |
| Dec 31 2022 | US$5m | US$948k | US$143m |
| Sep 30 2022 | n/a | n/a | US$272m |
| Jun 30 2022 | n/a | n/a | US$392m |
| Mar 31 2022 | n/a | n/a | US$461m |
| Dec 31 2021 | US$6m | US$664k | US$507m |
| Sep 30 2021 | n/a | n/a | US$569m |
| Jun 30 2021 | n/a | n/a | US$493m |
| Mar 31 2021 | n/a | n/a | US$417m |
| Dec 31 2020 | US$248k | US$240k | US$214m |
| Sep 30 2020 | n/a | n/a | US$48m |
| Jun 30 2020 | n/a | n/a | US$3m |
| Mar 31 2020 | n/a | n/a | -US$459k |
| Dec 31 2019 | US$240k | US$240k | -US$411k |
| Sep 30 2019 | n/a | n/a | -US$2m |
| Jun 30 2019 | n/a | n/a | -US$4m |
| Mar 31 2019 | n/a | n/a | -US$6m |
| Dec 31 2018 | US$240k | US$240k | -US$6m |
| Sep 30 2018 | n/a | n/a | -US$5m |
| Jun 30 2018 | n/a | n/a | -US$6m |
| Mar 31 2018 | n/a | n/a | -US$5m |
| Dec 31 2017 | US$240k | US$240k | -US$3m |
Compensazione vs Mercato: La retribuzione totale di Ming ($USD 5.31M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 2.11M ).
Compensazione vs guadagni: La retribuzione di Ming è aumentata nonostante l'azienda non sia redditizia.
AMMINISTRATORE DELEGATO
Ming Hsieh (68 yo)
8.5yrs
Mandato
US$5,309,167
Compensazione
Mr. Ming Hsieh has been an Independent Director of Fortinet, Inc. since April 2013. He is the Founder of Fulgent Genetics, Inc. and had been its President until May 2022 & serves as its Chief Executive Off...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chairman & CEO | 8.5yrs | US$5.31m | 28.52% $ 156.1m | |
| COO & President | 6.6yrs | US$1.79m | 1.42% $ 7.8m | |
| Chief Financial Officer | 8.8yrs | US$1.78m | 0.40% $ 2.2m | |
| Chief Scientific Officer & Laboratory Director | 8.2yrs | US$1.49m | 2.8% $ 15.3m | |
| General Counsel & Chief Privacy Officer | 2.5yrs | Nessun dato | Nessun dato | |
| VP of Operations & Compliance and GM of Houston Office | 4.1yrs | Nessun dato | Nessun dato | |
| Vice President of Business Development & Sales | 9.8yrs | Nessun dato | Nessun dato | |
| Vice President of Human Resources | 2.5yrs | Nessun dato | Nessun dato | |
| Chief Commercial Officer | 4.7yrs | Nessun dato | Nessun dato | |
| Chief Medical Officer | 3.5yrs | Nessun dato | Nessun dato | |
| President & Chief Scientific Officer of Fulgent Pharma | 2yrs | Nessun dato | Nessun dato |
4.7yrs
Durata media
58yo
Età media
Gestione esperta: Il team dirigenziale di FLGT è considerato esperto (durata media dell'incarico 4.7 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chairman & CEO | 8.5yrs | US$5.31m | 28.52% $ 156.1m | |
| Independent Non-Employee Director | 1.8yrs | US$625.60k | 0.0039% $ 21.2k | |
| Independent Director | 5.3yrs | US$270.50k | 0.061% $ 333.8k | |
| Independent Non-Employee Director | 2.3yrs | US$268.50k | 0.0078% $ 42.6k |
3.8yrs
Durata media
67yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di FLGT sono considerati esperti (durata media dell'incarico 3.8 anni).